🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT02996656
Recruiting Not applicable

Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery

NCT02996656 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2016-12
Last updated
2026-05-01

Condition(s) studied

Propionibacterium Infection

Investigational drug(s) / intervention(s)

Cefazolin →Ceftriaxone →

Cefazolin: Antibiotic that will be give before a Trauma or elective open shoulder surgery

Ceftriaxone: Antibiotic that will be give before a Trauma or elective open shoulder surgery

Study summary

INESS Antibiotic Prophylaxis in Orthopedic Guide recommends the use of Cefazolin at induction for all orthopaedic procedure with implantation of internal fixation device. With the increasing rate of identified P. acnes shoulder surgery infection despite the use of recommended skin preparation and preoperative prophylactic antibiotics, a question arises; Is Cefazolin the most effective prophylactic antibiotic for shoulder surgery? The objective of this study is to determine if Ceftriaxone is superior to Cefazolin as a prophylactic antibiotic for skin colonization with P. acnes in primary shoulder surgery

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 years and older * Male or female * Presenting normal skin on the shoulder aria Exclusion Criteria: * Used antibiotics or treated their skin with antibiotic gel, alcohol gel or cream or acne treatment in the last three months * Active infection at the surgical site or anywhere * Affected shoulder previously received radiotherapy * Allergic to one of the antimicrobial prophylaxis used * Open fracture * Life threatening or a limb threatening pathology * Liver or kidney failure

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital du Sacré-Cœur de Montréal Montreal Quebec Recruiting

On this site

📄 Rocephin (ceftriaxone) drug profile →

More Université de Montréal trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02996656 on ClinicalTrials.gov ↗ ← All trials in Canada